The Nuance of Nonrefundability: A Deep Dive into the Colorado Enterprise Zone Research and Development Tax Credit (C.R.S. § 39-22-508.5)

The Colorado Enterprise Zone (EZ) Research and Development (R&D) Tax Credit is a vital component of the state’s incentive structure, designed to spur innovation within economically distressed areas. Understanding the core concept of a nonrefundable tax credit is crucial for properly valuing and utilizing this significant incentive.

The Foundational Principle of Nonrefundable Tax Credits

A nonrefundable tax credit can reduce a taxpayer’s income tax liability to zero, but it cannot generate a cash refund if the credit amount exceeds the taxes owed.1 The unused portion is either lost or, as provided by Colorado statute, carried forward to offset future tax obligations.1

Detailed Analysis: Delineation of Credit Types and Constraints

The status of a tax credit—refundable versus nonrefundable—fundamentally dictates its utility and corresponding risk profile for a business. Nonrefundable credits serve as a direct reduction of the tax bill, meaning their benefit is strictly capped by the liability established on the state income tax return.2 They operate essentially as a discount on the tax obligation. For instance, if a company owes $200 in state income tax and is eligible for a $500 nonrefundable credit, the tax owed is reduced to $0. The remaining $300 of the credit is not returned to the taxpayer as cash; it is the unusable excess portion.2

This mechanism contrasts sharply with refundable tax credits. Refundable credits are treated as if the taxpayer has already made a payment to the taxing authority. If the total refundable credit exceeds the income tax liability, the difference is paid out to the taxpayer as a cash refund.1 Examples of such credits often occur at the federal level, such as the Earned Income Credit.2 Furthermore, a third category, partially refundable credits, exists where a regulator designates a specific portion of the credit to be refundable, while the remainder operates under nonrefundable rules, balancing immediate taxpayer relief with fiscal responsibility.2

The designation of the Colorado EZ R&D credit as nonrefundable confirms the legislature’s intent to subsidize EZ R&D activities through deferred tax savings rather than immediate direct public spending, which a refundable credit would entail.3 This structure ensures that only successful businesses that eventually generate state income tax revenue fully benefit from the incentive, thereby mitigating the state’s immediate fiscal impact. The credit is positioned purely as a liability management tool.

For a high-growth company, particularly a startup, the limitation of nonrefundability could render a tax credit immediately worthless if the business operates at a loss or has minimal taxable income in its early years.1 However, the inclusion of a robust carryforward provision fundamentally alters the nature of the nonrefundable credit. The indefinite carryforward rule for the Colorado R&D credit 4 transforms this restriction from a critical risk into a mechanism for creating a long-term, high-certainty deferred tax asset. The value of the credit is preserved and remains available for offset when the company eventually achieves profitability.

The table below summarizes the utilization characteristics across the spectrum of tax credits:

Table Title: Tax Credit Refundability Spectrum

Statutory and Regulatory Context of the Colorado EZ R&D Credit

The EZ R&D Credit is authorized under C.R.S. § 39-22-508.5 and is a central element of the Enterprise Zone Program, which aims to encourage economic development in 16 designated areas suffering from high unemployment, low per capita income, or slow population growth.4 This nonrefundable credit is explicitly structured to offset Colorado state income tax liability.3

Eligibility and Compliance Prerequisites

Eligibility for the credit is predicated on two fundamental requirements: geographic location and administrative compliance. The business must be located within a designated enterprise zone.4 Both new and existing businesses can qualify, provided they comply with state and federal laws. Notably, businesses in federally illegal industries, such as the marijuana industry, are ineligible.4

A critical mandate tied to the Enterprise Zone Program is the requirement that a business must maintain a physical presence in the same enterprise zone for three consecutive years to claim the credit.4 If a company relocates to a different enterprise zone, the three-year clock resets, and the company cannot claim the credit until the new three-year requirement is met.4 This structural penalty on mobility reinforces the state’s clear objective: to foster permanent, localized economic growth rather than simply offering a temporary R&D incentive irrespective of local commitment.

Before conducting the eligible activity, businesses must first complete a mandatory pre-certification application through the Office of Economic Development and International Trade (OEDIT) application portal.4 This step is paramount. The greatest immediate risk of losing an otherwise valid credit is administrative non-compliance with this timing requirement. The local EZ administrator reviews and approves the certification, ultimately issuing a tax credit certificate that must be included when filing with the Colorado Department of Revenue (CDOR).6 Compliance calendars must therefore prioritize the annual OEDIT pre-certification process to secure the basis for the eventual tax credit claim with CDOR.

Defining Qualified Research Expenses (QREs)

The credit is based on a percentage of the increase in qualified research expenses (QREs). To qualify, expenses must meet specific criteria similar to the federal R&D tax credit 5:

1. The research must lead to a new or improved product, process, service, or software.
2. The research must aim to eliminate technological uncertainty.
3. The research must be fundamentally technological in nature.
4. The research must involve a process of experimentation.5

Eligible costs include wages paid to employees directly involved in performing R&D activities within Colorado and contract research expenses.5 If a third party performs the research, that activity must also take place within an enterprise zone to qualify.4 The statute explicitly excludes certain expenses, such as the cost of land or land improvements, depreciable equipment, management surveys, costs related to adapting products for specific customer needs, and research funded by any government entity.4

Calculation and The Annual Claim Limitation

The Colorado R&D credit utilizes an incremental calculation method, which incentivizes annual growth in research spending within the EZ, and imposes a unique, mandatory annual pacing rule for its utilization.

The Incremental Calculation Formula

The credit is calculated based on the increase in current year QREs relative to a historical average:

1. Base Calculation: The base amount is calculated as the average of the QREs incurred during the two preceding tax years (Year -1 and Year -2).3 If the business had no research expenditures in one or both of those preceding years, the corresponding year’s expenditure is treated as zero when calculating the average base.4
2. Credit Determination: The generated credit amount equals 3% of the amount by which the current year’s QREs exceed this two-year average base.3

The 25% Annual Pacing Rule (Mandatory Distribution)

A critical limitation imposed by the statute is the mandatory distribution schedule. The total calculated credit (the 3% amount determined for the year) must be claimed equally over four tax years.3 In any single tax year, the taxpayer may claim no more than 25% of the total original credit, plus any applicable carryover amount from prior years.3

This 25% annual pacing represents an internal limit set by the state statute, defining the maximum credit available to the taxpayer in a given year. This is distinct from the external limit imposed by the nonrefundable status, which caps the usable credit at the amount of state income tax liability. A company must satisfy both limitations. Taxpayers cannot accelerate the utilization of the credit even if they have substantial tax liability; they are constrained by the 25% annual allowance. If the amount allowed by the 25% pacing rule is $10,000, but the company’s tax liability is only $5,000, only $5,000 is used, and the remaining $5,000 from the allowed claim must be carried forward indefinitely.3 The other 75% of the original credit carries forward automatically by virtue of its scheduled allowance in the next three years.

Table Title: Colorado EZ R&D Credit Utilization Constraints

CDOR Guidance: Navigating the Nonrefundable Limitation and Forms

Compliance requires meticulous tracking, primarily managed through the Colorado Department of Revenue (CDOR) Form DR 1366, the Enterprise Zone Credit and Carryforward Schedule.

CDOR Forms and the Certification Pipeline

Taxpayers must submit the certification documents, such as Forms DR 0074, DR 0076, or DR 0077, received from the Enterprise Zone Administrator along with their Colorado income tax return.6 The specific CDOR form utilized depends on the nature of the credit receipt:

• Form DR 1366: This form is used to calculate and track enterprise zone credits, including the R&D credit, when the taxpayer did not receive a refund certificate from OEDIT. It is the core document for tracking carryforward balances.7
• Form DR 1370: This form is used if OEDIT issued a refund certificate.7

Detailed Analysis of DR 1366: R&D Tracking (Part IV)

Form DR 1366 provides the specific mechanism for complying with the 25% pacing rule and tracking the indefinite carryforward. Worksheet 3 of the form is used to calculate the current year’s generated credit and determines the total amount available for utilization.7

Worksheet 3 is critical because it calculates the current year’s allowable claim:

• Line H calculates the mandatory 25% of the currently generated credit.7
• Line I includes any unused carryforward credit from prior years—the portion of previous 25% claims that were blocked by the nonrefundable liability cap.7
• Line J totals these amounts and transfers the result to Line 20 of DR 1366, which represents the total R&D credit available for use in the current year.7

Furthermore, Part IV of DR 1366 includes specific lines (Lines 21-23) that explicitly track the mandatory 25% allowances from the three prior years, ensuring the four-year claim schedule is enforced and transparently tracked for compliance.7

The Nonrefundable Limitation Mechanics (Section B of DR 1366)

The nonrefundable status is given formal effect through the general Investment Tax Credit limitation detailed in Section B of Form DR 1366. This section imposes a comprehensive cap on the total amount of specified investment credits, including the R&D credit, that can be used in any single tax year.7

To determine the final, usable amount, the taxpayer calculates the lesser of three constraints:

1. The taxpayer’s net tax liability for the current year.7
2. The statutory “Five Thousand Dollar Plus Fifty Percent Rule”: The sum of $5,000 plus 50% of the taxpayer’s net tax liability that is in excess of $5,000.7
3. The absolute maximum hard cap of $750,000.7

This composite limit ensures that the R&D credit is subject to a double-capping mechanism, which can influence utilization based on a company’s financial profile. For businesses with low profitability, the nonrefundable liability cap is the binding constraint. For established, highly profitable companies, the $5,000 + 50% rule may become the binding constraint, ensuring the state retains at least half of the tax burden above the initial threshold.7 The total amount of available credit (Line 24, Column A) is then compared against this limit, and the amount actually used (Column B) cannot exceed the Section B limit. Any amount disallowed due to this cap is added to the indefinite carryforward.

It is relevant to note that the state corporate income tax rate is scheduled to decrease from 4.40% to 4.0% starting January 1, 2025.8 Since the nonrefundable credit offset is directly proportional to the calculated tax liability, a lower statutory rate effectively means a lower maximum annual utilization capacity for a given amount of taxable income. Consequently, the time required to fully exhaust an accumulated R&D carryforward balance will increase slightly post-2024, emphasizing the value of the indefinite carryforward feature.

Indefinite Carryforward: Mitigating Nonrefundability for Growth Businesses

The indefinite carryforward provision of the Colorado EZ R&D credit (C.R.S. § 39-22-508.5) is the single most important structural feature that allows the nonrefundable credit to function as an effective, long-term tax planning asset.

The Unrestricted Duration

The statute explicitly guarantees that there is no limit on the number of years a business may carry forward the unused credit amount.4 This feature is particularly valuable and sets the R&D credit apart from other Colorado incentives, such as the Enterprise Zone Investment Tax Credit, which is generally limited to a 14-year carryforward.10 This distinction underscores the state’s long-term commitment to fostering R&D stability and investment.

For high-growth companies that experience initial losses followed by rapid scaling and high profitability, the indefinite carryforward is critical. It ensures the value of the QREs incurred during the research and development phase is preserved. The indefinite life of this tax credit carryforward provides greater certainty regarding its realization under financial accounting standards (e.g., ASC 740), compared to credits with fixed expiration windows, which typically require complex probability assessments and valuation allowances. This enhances the financial statement quality for the taxpayer.

Furthermore, the age of the credit carryforward must still be meticulously tracked, as certain utilization rules depend on the credit’s vintage. Specifically, the $\$750,000$ hard cap on utilization established in Section B of DR 1366 does not apply to any credit carried forward from a tax year prior to 2014.7 Therefore, the ability to track the exact year each portion of the credit was generated is essential, as older credits may offer a higher potential for annual utilization under certain circumstances.

Detailed Illustrative Example: Maximizing and Tracking the Nonrefundable Credit

The following example demonstrates how the nonrefundable status, the 25% pacing rule, and the carryforward mechanism interact over time.

Scenario Parameters

A technology firm operating within a Colorado Enterprise Zone generated its first EZ R&D credit in Year 1.

• Tax Year 0 (Base Period): QREs Year -2 = $1,000,000. QREs Year -1 = $1,200,000. The Base Average for calculation is $(\$1,000,000 + \$1,200,000) / 2 = \$1,100,000$.
• Credit Generated (Year 1):

• Current QREs (Year 1) = $1,500,000.
• Excess QREs over Base = $\$1,500,000 – \$1,100,000 = \$400,000$.
• Total Generated Credit (3% of Excess) = $0.03 \times \$400,000 = \$12,000$.

• Annual Allowed Claim (25% Pacing): 25% of $12,000 = $3,000 per year for Year 1, 2, 3, and 4.

Utilization and Carryforward Tracking (Years 1-4)

For simplicity, this example assumes the company’s net tax liability is the binding nonrefundable cap, meaning the Section B $5,000 + 50 \%$ rule and the $750,000 cap are not active constraints.

Table Title: Colorado EZ R&D Credit Utilization Timeline and Carryforward Analysis

Analysis of the Utilization Path

In this scenario, the company was highly successful in generating the credit in Year 1 ($12,000 total) but lacked sufficient tax liability to use the full allowed 25% portion ($3,000) in Years 1, 2, and 3.

• In Year 1, the company could only use $1,500 of the allowed $3,000. The remaining $1,500 was not lost but was immediately placed into the Unused Carryforward pool, which rolls over indefinitely.
• In Year 3, the cumulative Current Available Claim (the scheduled $3,000 portion for Year 3 plus the accumulated $2,500 carryforward from Years 1 and 2) reached $5,500. However, due to the nonrefundable nature of the credit, only the net tax liability of $500 could be utilized, causing the remaining $5,000 to accumulate in the carryforward pool. This demonstrates how low profitability rapidly forces the accumulation of large carryforward balances.
• In Year 4, when the company achieved high profitability ($50,000 liability), it had access to the final 25% scheduled allowance ($3,000) and the entire accumulated Unused Carryforward balance ($5,000), totaling $8,000. Because the tax liability exceeded this available amount, the entire $8,000 was utilized, fully exhausting the original $12,000 credit.

Had this credit been subject to a short carryforward limit (e.g., a three-year expiration), the $8,000 realized in Year 4 would have been lost, significantly diminishing the value of the original investment. The indefinite carryforward provision is the mechanism that guarantees the maximum realization of the generated credit, validating the tax planning strategy for growth companies.

Conclusion and Strategic Recommendations

The Colorado EZ R&D Tax Credit is a powerful, long-term incentive defined by its nonrefundable status and mitigated by a highly favorable indefinite carryforward provision. Effective management of this credit requires rigorous adherence to state-level compliance and proactive financial modeling.

Summary of Key Compliance Imperatives

1. Prioritize OEDIT Pre-certification: The validity of the credit relies entirely on the successful completion of the pre-certification application through OEDIT before the eligible R&D activity commences.4 This administrative requirement is a non-negotiable gateway to claiming the credit.
2. Master Layered Limitations: Businesses must account for two distinct utilization constraints simultaneously. First, the 25% annual pacing rule dictates the maximum amount available for use in any given year. Second, the nonrefundable tax liability cap (including the complex $5,000 + 50 \%$ rule detailed in DR 1366) determines the maximum amount usable against the tax bill.7
3. Meticulous Carryforward Tracking: Form DR 1366 is the central document for managing the credit. Accurate completion of Worksheet 3 and Part IV is essential to correctly calculate the incremental credit, track the scheduled 25% annual portions, and maintain the precise balance of accumulated, unused carryforward credit across indefinite tax years.7

Strategic Recommendations for Optimization

1. Integrate Long-Term Forecasting: The nonrefundable credit balance should be treated as a highly reliable, non-expiring deferred tax asset. Financial forecasts must explicitly model the amortization of this asset against projected future Colorado tax liabilities, adjusting for the statutory corporate income tax rate decrease commencing in 2025.8
2. Establish Permanent Document Retention: Given the indefinite carryforward period 4, documentation supporting the QREs for the year the credit was generated (including payroll records, project narratives, and EZ location verification) must be archived indefinitely. This rigorous record-keeping is necessary to defend the credit’s generation basis decades later, should its utilization extend across many tax years.

Manage QRE Base Strategically: Since the credit is based on the increase over the prior two-year average 3, any significant, sustained decrease in QRE spending will raise the base average in future years, making subsequent credit generation more difficult. Strategic planning should focus on maximizing consistency and growth in qualified R&D expenditures within the enterprise zone.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/